Zavation Medical Products Acquires Choice Spine Holdings

Zavation Medical Products, LLC, a portfolio company of Gemspring Capital, has acquired Choice Spine Holdings, Inc., a designer and manufacturer of spinal implant systems based in Knoxville, Tennessee. The terms of the transaction were not disclosed. This acquisition is expected to enhance Zavation’s product portfolio and commercial reach across both inpatient and outpatient settings.

Founded in 2006, Choice Spine has built a strong reputation for its comprehensive range of spinal implant and instrumentation systems, which include cervical, thoracolumbar, and interbody applications. The company is recognized for its commitment to user-driven design and robust customer service, supported by a national distributor network.

The acquisition allows Zavation to leverage its vertically integrated manufacturing platform to accelerate innovation and speed to market. Choice Spine will continue to operate under its brand as both companies work towards a unified organization. Concurrently, Zavation has appointed Derek Kuyper as the Chief Executive Officer of the combined entity. Kuyper, who previously served as Zavation’s Chief Commercial Officer, brings over 15 years of leadership experience in the spinal device industry.

“I am honored to step into the role of CEO and lead Zavation’s next phase of growth,” said Kuyper. “The acquisition of Choice Spine advances our strategy to build a scaled, innovation-driven spinal platform.” He emphasized that Choice Spine’s complementary portfolio and strong distributor relationships align closely with Zavation’s values.

Steve Ainsworth, Co-President of Choice Spine, will remain with the company to facilitate integration and ensure continuity. “Partnering with Zavation allows us to continue delivering the innovation and quality our distributors and surgeons expect,” Ainsworth stated.

Chirag Hirawat, Principal at Gemspring Capital, noted that the acquisition strengthens Zavation’s competitive position in the spinal implant market. “Choice Spine is a highly complementary addition,” he added, expressing excitement about supporting the leadership team in executing the company’s long-term growth strategy.

With this acquisition, Zavation aims to enhance its market share in the spinal implant sector, particularly in Tennessee and across the United States. The combined entity will offer a broader range of spinal implant systems, enhancing its product offerings in cervical and thoracolumbar applications.

Looking ahead, the integration of the two companies will focus on aligning corporate cultures and operational systems while maintaining brand identity during the transition. The acquisition is expected to create synergies through cross-selling opportunities and improved supply chain efficiencies, positioning Zavation for continued growth in the evolving healthcare landscape.